Our Companies
We unite breakthrough technologies, experienced operators, and scaled manufacturing to turn innovations into accessible products–from ultra‑rapid molecular tests to digital and visual lateral flow, genetic testing, and patch‑based solutions. Together, our companies deliver real‑time, definitive results that help people act with confidence at home and near the patient.
Sapphiros Cambridge aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near patient and at-home testing for infectious disease or generic indications.
Sapphiros Hove is a material and process innovation and technology centre of excellence, with high speed printed electronics manufacturing, in-house proprietary conductive inks and printed components and extreme volume lateral flow manufacturing capability using proprietary lateral flow formats.
The SatioPatch™ Platform provides consumer-based diagnosis through a convenient and simple to use patch utilizing a wide variety of technologies for an increasing demand for rapid, point of care diagnosis.
Sapphiros Laboratories is a leading provider of genetic and COVID-19 testing. Our national scale and comprehensive clinical and digital solutions enable us to provide a seamless collection, testing and reporting solution.
GrapheneDx is designing a device that will put the power of the highest performing diagnostics in the palm of your hand and the comfort of your home. Our platform technology will enable better and faster health management anywhere, anytime.